NCT06336096View on ClinicalTrials.gov

A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

June 19, 2024

Study Completion Date

June 19, 2024

Conditions
Pain
Interventions
DRUG

Suzetrigine

Tablet(s) for oral administration.

DRUG

Suzetrigine

Tablet(s) and Suspension for oral administration.

Trial Locations (1)

85283

Celerion - Tempe, Tempe

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT06336096 - A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine | Biotech Hunter | Biotech Hunter